Serum CA19-9 alterations during preoperative gemcitabine-based chemoradiation therapy for resectable invasive ductal carcinoma of the pancreas as an indicator for therapeutic selection and survival

Hidenori Takahashi, Hiroaki Ohigashi, Osamu Ishikawa, Hidetoshi Eguchi, Kunihito Gotoh, Terumasa Yamada, Akihiko Nakaizumi, Hiroyuki Uehara, Yasuhiko Tomita, Kinji Nishiyama, Masahiko Yano

Research output: Contribution to journalArticlepeer-review

56 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Serum CA19-9 alterations during preoperative gemcitabine-based chemoradiation therapy for resectable invasive ductal carcinoma of the pancreas as an indicator for therapeutic selection and survival'. Together they form a unique fingerprint.

Medicine & Life Sciences